Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Newly discovered protein suggests novel tumorigenic pathway

22.10.2004


Scientists in Tokyo have discovered a new protein, named PICT-1, that is involved in regulating PTEN, the second most commonly mutated tumor suppressor in human tumors. This discovery suggests the possibility of a new tumorigenic pathway that is due to defects in a protein involved in stabilizing PTEN rather than defects in PTEN itself.


The research appears as the "Paper of the Week" in the October 29 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molecular Biology journal.


Mutations in the PTEN tumor suppressor are found in a variety of human cancers including breast and prostate cancers. Approximately 20 percent of the mutations are located in a segment of 70 amino acids at the C-terminus of PTEN. These mutations lead to the rapid degradation of PTEN in cells, indicating that this region is critical for ensuring PTEN stability.

Studies have shown that cells add phosphate molecules to specific serine and threonine residues within the C-terminal segment to stabilize PTEN. Curious about the proteins involved in this stabilization, Dr. Tomohiko Maehama and his colleagues at the Tokyo Metropolitan Institute of Medical Science and the Tokyo Metropolitan University screened a library of human brain cDNA to find proteins that interact with PTEN. They identified a new protein that binds to the C-terminus of PTEN and named it PICT-1 (protein interacting with the carboxyl terminus 1).



Maehama and his colleagues discovered that PTEN molecules with mutations in their C-terminus are unable to bind to PICT-1, and that PICT-1 stabilizes PTEN by regulating the phosphorylation of a serine in the C-terminal segment. "From scientific point of view, it should be noted that PICT-1 is the first protein that interacts with the PTEN protein and regulates its phosphorylation," said Maehama.

The researchers hypothesize that PICT-1 may affect phosphorylation by activating a kinase or inhibiting a phosphatase. The identification of PTEN regulators has been a tremendously difficult problem and this research represents a huge breakthrough.

Maehama explained that this discovery indicates that cells with impaired PICT-1 function may become cancerous because of the resulting instability in PTEN. This would represent a new tumorigenic pathway that is not due to a defective PTEN gene but rather a loss of PTEN function caused by PICT-1. If this is the case, then this new type of tumor may be treated with rapamycin or related drugs that are often used in cancers resulting from PTEN loss of function.

Nicole Kresge | EurekAlert!
Further information:
http://www.asbmb.org

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>